AJKD this month has an extended editorial section on the KDOQI guidelines for CKD. It is now 10 years since these guidelines were introduced and their impact on nephrology has been significant, not least due to the fact that many more patients are now recognized as having early CKD that may have been missed in the past. These patients with moderately reduced GFRs, while unlikely to progress to ESRD, still have a significantly increased risk of cardiovascular morbidity and mortality.
The articles comprise a series of commentaries written by members of the editorial board of AJKD and examine the impact of these guidelines on the NKF itself, research, primary care, clinical laboratories (which now routinely report eGFRs) and the practice of nephrology around the world.
No comments:
Post a Comment
Renal Fellow Network encourages comments and discussion regarding the posts. Do not post any comments that are commercial or advertising in nature. Posts will be deleted if commercial or advertising comments are made. Internet users commenting on the Renal Fellow Network must post information which is true and correct to their knowledge. Sources to health/medical claims must be provided when relevant. Moderators reserve the right to erase, without notification, any comment they would judge inappropriate.